FrancophonIA/ELRC3.0 huggingface dataset:
English: The most frequently (seen in ≥ 1% of patients) reported adverse reactions associated with the use of olanzapine in clinical trials were somnolence, weight gain, eosinophilia, elevated prolactin, cholesterol, glucose and triglyceride levels (see section 4.4), glucosuria, increased appetite, dizziness, akathisia, parkinsonism, leukopenia, neutropenia (see section 4.4), dyskinesia, orthostatic hypotension, anticholinergic effects, transient asymptomatic elevations of hepatic aminotransferases (see section 4.4), rash, asthenia, fatigue, pyrexia, arthralgia, increased alkaline phosphatase, high gamma glutamyltransferase, high uric acid, high creatine phosphokinase and oedema.
Slovenian: Najpogosteje poročani (opažene pri ≥ 1 % bolnikov) neželeni učinki, povezani z uporabo olanzapina v kliničnih preskušanjih, so bili zaspanost, povečanje telesne mase, eozinofilija, zvišane ravni prolaktina, holesterola, glukoze in trigliceridov (glejte poglavje 4.4), glikozurija, povečan apetit, omotica, akatizija, parkinsonizem, levkopenija, nevtropenija (glejte poglavje 4.4), diskinezija,
English: Each coated tablet contains 2.5 mg olanzapine.
Slovenian: Ena obložena tableta vsebuje 2,5 mg olanzapina.
English: Neuroleptic malignant syndrome (see section
Slovenian: Nevroleptični maligni sindrom (glejte poglavje 4.4)12
English: Contents of the pack and other information
Slovenian: Shranjevanje zdravila ZYPREXA Vsebina pakiranja in dodatne informacije
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON OF VIAL OF POWDER
Slovenian: PODATKI NA ZUNANJI OVOJNINI ŠKATLA Z VIALO PRAŠKA
English: PHARMACEUTICAL FORM Powder for solution for injection Yellow lyophilised powder.
Slovenian: FARMACEVTSKA OBLIKA prašek za raztopino za injiciranje.
English: In
Slovenian: Pri
English: After reconstitution each ml of the solution contains 5 mg olanzapine.
Slovenian: Po pripravi vsak ml raztopine vsebuje 5 mg olanzapina.
English: Oestrous cycles were affected at doses of 1.1 mg/kg (3 times the maximum human dose) and reproduction parameters were influenced in rats given 3 mg/kg (9 times the maximum human dose).
Slovenian: 3 mg/kg (9-kratni maksimalni odmerek za človeka) pa so pri podganah vplivali na parametre reprodukcije.
English: INFORMATION IN BRAILLE ZYPREXA 2.5 mg
Slovenian: PODATKI V BRAILLOVI PISAVI ZYPREXA 2,5 mg
English: Administer the solution intramuscularly.
Slovenian: Raztopino injicirajte intramuskularno.
English: INFORMATION IN BRAILLE ZYPREXA 15 mg
Slovenian: PODATKI V BRAILLOVI PISAVI ZYPREXA 15 mg
English: ZYPREXA 10 mg coated tablets are white imprinted with “LILLY” and a numeric identicode “4117”.
Slovenian: ZYPREXA 10 mg obložene tablete so bele ter imajo natisnjeno oznako »LILLY« in numerično identifikacijo »4117«.
English: Marketing Authorisation Holder Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.
Slovenian: IMETNIK DOVOLJENJA ZA PROMET Z ZDRAVILOM Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Nizozemska.
English: MARKETING AUTHORISATION HOLDER Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.
Slovenian: Imetnik dovoljenja za promet z zdravilom Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Nizozemska.
English: ZYPREXA 20 mg coated tablets Pink, elliptical, coated tablets debossed with “LILLY” and a numeric identicode, “4420”.
Slovenian: Elitične, rožnate, obložene tablete z vtisnjenim napisom "LILLY" in številčno identifikacijsko oznako “4420”.
English: ZYPREXA 15 mg coated tablets Elliptical, blue, coated tablets debossed with “LILLY” and a numeric identicode “4415”.
Slovenian: Eliptične, modre, obložene tablete z vtisnjenim napisom "LILLY" in številčno identifikacijsko oznako “4415”.
English: Each coated tablet contains 20 mg olanzapine.
Slovenian: Ena obložena tableta vsebuje 20 mg olanzapina.
English: • The active substance is olanzapine.
Slovenian: - Učinkovina je olanzapin.
English: ZYPREXA 7.5 mg coated tablets are white imprinted with “LILLY” and a numeric identicode “4116”.
Slovenian: ZYPREXA 7,5 mg obložene tablete so bele ter imajo natisnjeno oznako »LILLY« in numerično identifikacijo »4116«.
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 10 mg olanzapine per vial
Slovenian: VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ENOT Viala vsebuje 10 mg olanzapina.
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 10 mg powder for solution for injection olanzapine
Slovenian: ZYPREXA 10 mg prašek za raztopino za injiciranje olanzapin
English: LIST OF EXCIPIENTS Contains lactose monohydrate see package leaflet for further information
Slovenian: SEZNAM POMOŽNIH SNOVI Vsebuje laktozo monohidrat.
English: Lactose monohydrate Tartaric acid, E334
Slovenian: 6.1 Seznam pomožnih snovi laktoza monohidrat vinska kislina, E344 klorovodikova kislina natrijev hidroksid
English: ZYPREXA 2.5 mg coated tablets
Slovenian: ZYPREXA 2,5 mg obložene tablete
English: Excipient with known effect: Each coated tablet contains 156 mg lactose monohydrate.
Slovenian: Pomožna snov z znanim učinkom: Ena obložena tableta vsebuje 156 mg laktoze monohidrata.
English: ZYPREXA 5 mg coated tablets are white imprinted with “LILLY” and a numeric identicode “4115”.
Slovenian: ZYPREXA 5 mg obložene tablete so bele ter imajo natisnjeno oznako »LILLY« in numerično identifikacijo »4115«.
English: 1 mg olanzapine is retained in the vial and syringe, thus allowing delivery of 10mg olanzapine.
Slovenian: Če sterilno brizgo napolnete z 2,0 ml raztopine, 1 mg olanzapina ostane v viali in brizgi, kar omogoča injiciranje 10 mg olanzapina.
English: INFORMATION IN BRAILLE ZYPREXA 10 mg
Slovenian: PODATKI V BRAILLOVI PISAVI ZYPREXA 10 mg
English: INFORMATION IN BRAILLE ZYPREXA 5 mg
Slovenian: PODATKI V BRAILLOVI PISAVI ZYPREXA 5 mg
English: Excipient with known effect: Each coated tablet contains 178 mg lactose monohydrate.
Slovenian: Pomožna snov z znanim učinkom: Ena obložena tableta vsebuje 178 mg laktoze monohidrata.
English: Coated tablet
Slovenian: FARMACEVTSKA OBLIKA obložena tableta
English: Do not store above 25º C. Do not freeze.
Slovenian: Shranjujte pri temperaturi do 25 ºC.
English: Excipient with known effect: Each coated tablet contains 102 mg lactose monohydrate.
Slovenian: Pomožna snov z znanim učinkom: Ena obložena tableta vsebuje 102 mg laktoze monohidrata.
English: Each coated tablet contains 5 mg olanzapine.
Slovenian: Ena obložena tableta vsebuje 5 mg olanzapina.
English: In female versus male subjects administered oral olanzapine the mean elimination half life was somewhat prolonged (36.7 versus 32.3 hrs) and the clearance was reduced (18.9 versus 27.3 l/hr).
Slovenian: Po dajanju peroralnega olanzapina ženskam v primerjavi z moškimi je bil srednji razpolovni čas izločanja nekoliko podaljšan (36,7 v primerjavi z 32,3 ure) in očistek zmanjšan (18,9 v primerjavi s
English: 1 vial EU/1/96/022/017 Powder for solution for injection.
Slovenian: EU/1/96/022/017 Prašek za raztopino za injiciranje.
English: In renally impaired patients (creatinine clearance < 10 ml/min) versus healthy subjects administered oral olanzapine, there was no significant difference in mean elimination half-life (37.7 versus 32.4 hr) or clearance (21.2 versus 25.0 l/hr).
Slovenian: Okvarjeno delovanje ledvic Pri bolnikih z okvarjenim delovanjem ledvic (očistek kreatinina < 10 ml/min) v primerjavi z zdravimi osebami ni bilo značilne razlike v srednjem razpolovnem času izločanja (37,7 v primerjavi z 32,4 ure)
English: Each coated tablet contains 15 mg olanzapine.
Slovenian: Ena obložena tableta vsebuje 15 mg olanzapina.
English: What you need to know before you take ZYPREXA 3.
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo ZYPREXA Ne jemljite zdravila ZYPREXA:
English: (tablet coating) shellac, macrogol, propylene glycol, polysorbate 80 and indigo carmine colour (E132), ethanol anhydrous, isopropyl alcohol, butyl alcohol, ammonium hydroxide
Slovenian: ZYPREXA 2,5 mg, 5 mg, 7,5 mg, 10 mg tablete (obloga tablete) šelak, makrogol, propilenglikol, polisorbat 80 in barvilo indigotin (E132), brezvodni etanol, izopropilalkohol, butanol, amonijev hidroksid
English: Excipient with known effect: Each coated tablet contains 312 mg lactose monohydrate.
Slovenian: Pomožna snov z znanim učinkom: Ena obložena tableta vsebuje 312 mg laktoze monohidrata.
English: ZYPREXA 20 mg coated tablets
Slovenian: ZYPREXA 20 mg obložene tablete
English: New born infant exposed to antipsychotics (including olanzapine) during the third trimester of pregnancy are at risk of adverse reactions including extrapyramidal and/or withdrawal symptoms that may vary in severity and duration following delivery.
Slovenian: (vključno z olanzapinom), obstaja tveganje za pojav neželenih učinkov, vključno z ekstrapiramidnimi in/ali odtegnitvenimi simptomi, katerih jakost in čas trajanja po porodu sta lahko različna.
English: ZYPREXA 10 mg coated tablets
Slovenian: ZYPREXA 10 mg obložene tablete
English: Excipient with known effect: Each coated tablet contains 234 mg lactose monohydrate.
Slovenian: Pomožna snov z znanim učinkom: Ena obložena tableta vsebuje 234 mg laktoze monohidrata.
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 7.5 mg coated tablets Olanzapine
Slovenian: IME ZDRAVILA ZYPREXA 7,5 mg obložene tablete olanzapin
English: ZYPREXA contains lactose
Slovenian: Zdravilo ZYPREXA vsebuje laktozo
English: Each coated tablet contains 10 mg olanzapine.
Slovenian: Vsaka viala vsebuje 10 mg olanzapina.
English: • If you get any side effects talk to your doctor or pharmacist.
Slovenian: - Če opazite katerikoli neželeni učinek, se posvetujte s svojim zdravnikom ali s farmacevtom.
English: A lower dose (5 mg or 7.5 mg) may be given, on the basis of individual clinical status, which should also include consideration of medicinal products already administered either for maintenance or acute treatment (see section 4.4).
Slovenian: Glede na individualno klinično stanje, katerega ocena naj upošteva tudi že dana zdravila za vzdrževalno ali akutno zdravljenje (glejte poglavje 4.4), lahko damo nižji odmerek
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 20 mg coated tablets olanzapine
Slovenian: IME ZDRAVILA ZYPREXA 20 mg obložene tablete olanzapin
English: EU/1/96/022/011 - ZYPREXA - 7.5 mg - coated tablets - 28 tablets, per box.
Slovenian: EU/1/96/022/011 - ZYPREXA - 7,5 mg - obložene tablete - 28 tablet na škatlo.
English: Leukopenia10
Slovenian: Oteklina Pireksija10
English: Tardive dyskinesia11 Amnesia 9
Slovenian: (vključno z okulogiracijo)11 Tardivne diskinezije11
English: Excipient with known effect: Each coated tablet conatins 238 mg lactose monohydrate.
Slovenian: Pomožna snov z znanim učinkom: Ena obložena tableta vsebuje 238 mg laktoze monohidrata.
English: Following short term treatment (median duration 47 days), weight gain ≥ 7 % of baseline body weight was very common (22.2 %), ≥ 15 % was common (4.2 %) and ≥ 25 % was uncommon (0.8 %).
Slovenian: S kratkoročnim zdravljenjem (srednje trajanje 47 dni) povezano zvečanje telesne mase za ≥ 7 % od osnovne telesne mase je bilo zelo pogosto (22,2 %), ≥ 15 %
English: SPECIAL STORAGE CONDITIONS Do not store above 25º C. Store in original package in order to protect from light
Slovenian: POSEBNA NAVODILA ZA SHRANJEVANJE Shranjujte pri temperaturi do 25 ºC.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each coated tablet contains 7.5 mg olanzapine
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN Ena obložena tableta vsebuje 7,5 mg olanzapina.
English: ZYPREXA 5 mg coated tablets
Slovenian: ZYPREXA 5 mg obložene tablete
English: EU/1/96/022/006 - ZYPREXA - 7.5 mg - coated tablets - 56 tablets, per box.
Slovenian: EU/1/96/022/006 - ZYPREXA - 7,5 mg - obložene tablete - 56 tablet na škatlo.
English: A vial of ZYPREXA can provide you with 10 mg of olanzapine.
Slovenian: Iz viale zdravila ZYPREXA lahko dobimo 10 mg olanzapina.
English: Postural hypotension was infrequently observed in the elderly in oral olanzapine clinical trials.
Slovenian: V kliničnih preskušanjih peroralnega olanzapina so pri starejših redko poročali o posturalni hipotenziji.
English: EU/1/96/022/037 - ZYPREXA - 7.5 mg - coated tablets - 98 tablets, per box.
Slovenian: EU/1/96/022/037 - ZYPREXA - 7,5 mg - obložene tablete - 98 tablet na škatlo.
English: EU/1/96/022/029 - ZYPREXA - 2.5 mg - coated tablets - 70 tablets, per box.
Slovenian: EU/1/96/022/029 - ZYPREXA - 2,5 mg - obložene tablete - 70 tablet na škatlo.
English: EU/1/96/022/031 - ZYPREXA - 7.5 mg - coated tablets - 70 tablets, per box.
Slovenian: EU/1/96/022/031 - ZYPREXA - 7,5 mg - obložene tablete - 70 tablet na škatlo.
English: EU/1/96/022/033 - ZYPREXA - 15 mg - coated tablets - 70 tablets, per box.
Slovenian: EU/1/96/022/033 - ZYPREXA - 15 mg - obložene tablete - 70 tablet na škatlo.
English: EU/1/96/022/034 - ZYPREXA - 20 mg - coated tablets - 70 tablets, per box.
Slovenian: EU/1/96/022/034 - ZYPREXA - 20 mg - obložene tablete - 70 tablet na škatlo.
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 2.5 mg coated tablets Olanzapine
Slovenian: IME ZDRAVILA ZYPREXA 2,5 mg obložene tablete olanzapin
English: EU/1/96/022/035 - ZYPREXA - 2.5 mg - coated tablets - 98 tablets, per box.
Slovenian: EU/1/96/022/035 - ZYPREXA - 2,5 mg - obložene tablete - 98 tablet na škatlo.
English: EU/1/96/022/009 - ZYPREXA - 10 mg - coated tablets - 28 tablets, per box.
Slovenian: EU/1/96/022/009 - ZYPREXA - 10 mg - obložene tablete - 28 tablet na škatlo.
English: EU/1/96/022/023 - ZYPREXA - 2.5 mg - coated tablets - 35 tablets, per box.
Slovenian: EU/1/96/022/023 - ZYPREXA - 2,5 mg - obložene tablete - 35 tablet na škatlo.
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 10 mg coated tablets Olanzapine
Slovenian: IME ZDRAVILA ZYPREXA 10 mg obložene tablete olanzapin
English: EU/1/96/022/012 - ZYPREXA - 15 mg - coated tablets - 28 tablets, per box.
Slovenian: EU/1/96/022/012 - ZYPREXA - 15 mg - obložene tablete - 28 tablet na škatlo.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 7.5 mg COATED TABLETS: BLISTER FOIL LABEL
Slovenian: ZYPREXA 7,5 mg OBLOŽENE TABLETE: OZNAKA FOLIJE PRETISNEGA OMOTA
English: 14 Observed for fasting normal levels at baseline (< 1.016 mmol/l) which increased to high
Slovenian: 14 Opazovano pri osnovnih normalnih ravneh na tešče (< 1,016 mmol/l), ki so se povišale na visoke (≥ 1,467 mmol/l) in spremembe v ravneh trigliceridov na tešče z mejnih osnovnih vrednosti
English: EU/1/96/022/025 - ZYPREXA - 7.5 mg - coated tablets - 35 tablets, per box.
Slovenian: EU/1/96/022/025 - ZYPREXA - 7,5 mg - obložene tablete - 35 tablet na škatlo.
English: EU/1/96/022/040 - ZYPREXA - 20 mg - coated tablets - 98 tablets, per box.
Slovenian: EU/1/96/022/040 - ZYPREXA - 20 mg - obložene tablete - 98 tablet na škatlo.
English: Very common symptoms in overdose (> 10 % incidence) include tachycardia, agitation/aggressiveness, dysarthria, various extrapyramidal symptoms, and reduced level of consciousness ranging from sedation to coma.
Slovenian: vznemirjenost/nasilnost, dizartrijo, različne ekstrapiramidne simptome in motnje zavesti v razponu od sedacije do kome.
English: Temporal association of treatment with IM olanzapine with hypotension, bradycardia, respiratory depression and death has been very rarely (< 0.01 %) reported particularly in patients who have received benzodiazepines and/or other antipsychotics (see section 4.8).
Slovenian: Zelo redko (< 0,01 %) so zlasti pri bolnikih, ki so prejemali benzodiazepine in/ali druge antipsihotike, poročali o časovni povezavi zdravljenja z i.m.
English: EU/1/96/022/002 - ZYPREXA - 2.5 mg - coated tablets - 28 tablets, per box.
Slovenian: EU/1/96/022/002 - ZYPREXA - 2,5 mg - obložene tablete - 28 tablet na škatlo.
English: EU/1/96/022/028 - ZYPREXA - 20 mg - coated tablets - 35 tablets, per box.
Slovenian: EU/1/96/022/028 - ZYPREXA - 20 mg - obložene tablete - 35 tablet na škatlo.
English: EU/1/96/022/032 - ZYPREXA - 10 mg - coated tablets - 70 tablets, per box.
Slovenian: EU/1/96/022/032 - ZYPREXA - 10 mg - obložene tablete - 70 tablet na škatlo.
English: How to store ZYPREXA
Slovenian: Shranjevanje zdravila ZYPREXA
English: EU/1/96/022/019 - ZYPREXA - 2.5 mg - coated tablets - 56 tablets, per box.
Slovenian: EU/1/96/022/019 - ZYPREXA - 2,5 mg - obložene tablete - 56 tablet na škatlo.
English: EU/1/96/022/004 - ZYPREXA - 5 mg - coated tablets - 28 tablets, per box.
Slovenian: EU/1/96/022/004 - ZYPREXA - 5 mg - obložene tablete - 28 tablet na škatlo.
English: Other common side effects(may affect up to 1 in 10 people) include changes in the levels of some blood cells, circulating fats and early in treatment, temporary increases in liver enzymes; increases in the level of sugars in the blood and urine; increases in levels of uric acid and creatine phosphokinase in the blood; feeling more hungry; dizziness; restlessness; tremor; unusual movements (dyskinesias); constipation; dry mouth; rash; loss of strength; extreme tiredness; water retention leading to swelling of the hands, ankles or feet; fever; joint pain; and sexual dysfunctions such as decreased libido in males and females or erectile dysfunction in males.
Slovenian: Drugi pogosti neželeni učinki (lahko prizadenejo do 1 od 10 bolnikov) vključujejo spremembe v ravneh nekaterih krvnih celic, maščob v krvnem obtoku in v začetnih obdobjih zdravljenja, začasno povišanje jetrnih encimov, zvišanja v ravni sladkorjev v krvi in urinu, zvišanja v ravni sečne kisline in kreatin-fosfokinaze v krvi, večji občutek lakote, omotico, nemirnost, tresenje, nenavadne gibe
English: EU/1/96/022/014 - ZYPREXA - 20 mg - coated tablets - 28 tablets, per box.
Slovenian: EU/1/96/022/014 - ZYPREXA - 20 mg - obložene tablete - 28 tablet na škatlo.
English: ZYPREXA 10 mg coated tablets Round, white, coated tablets imprinted with “LILLY” and a numeric identicode “4117”.
Slovenian: Okrogle, bele, obložene tablete z vtisnjenim napisom "LILLY" in številčno identifikacijsko oznako “4117”.
English: EU/1/96/022/027 - ZYPREXA - 15 mg - coated tablets - 35 tablets, per box.
Slovenian: EU/1/96/022/027 - ZYPREXA - 15 mg - obložene tablete - 35 tablet na škatlo.
English: EU/1/96/022/038 - ZYPREXA - 10 mg - coated tablets - 98 tablets, per box.
Slovenian: EU/1/96/022/038 - ZYPREXA - 10 mg - obložene tablete - 98 tablet na škatlo.
English: ZYPREXA 15 mg coated tablets
Slovenian: ZYPREXA 15 mg obložene tablete
English: EU/1/96/022/030 - ZYPREXA - 5 mg - coated tablets - 70 tablets, per box.
Slovenian: EU/1/96/022/030 - ZYPREXA - 5 mg - obložene tablete - 70 tablet na škatlo.
English: EU/1/96/022/022 - ZYPREXA - 20 mg - coated tablets - 56 tablets, per box.
Slovenian: EU/1/96/022/022 - ZYPREXA - 20 mg - obložene tablete - 56 tablet na škatlo.
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 5 mg coated tablets Olanzapine
Slovenian: IME ZDRAVILA ZYPREXA 5 mg obložene tablete olanzapin
English: EU/1/96/022/024 - ZYPREXA - 5 mg - coated tablets - 35 tablets, per box.
Slovenian: EU/1/96/022/024 - ZYPREXA - 5 mg - obložene tablete - 35 tablet na škatlo.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 2.5 mg COATED TABLETS: BLISTER FOIL LABEL
Slovenian: ZYPREXA 2,5 mg OBLOŽENE TABLETE: OZNAKA FOLIJE PRETISNEGA OMOTA
English: EU/1/96/022/039 - ZYPREXA - 15 mg - coated tablets - 98 tablets, per box.
Slovenian: EU/1/96/022/039 - ZYPREXA - 15 mg - obložene tablete - 98 tablet na škatlo.
English: EU/1/96/022/026 - ZYPREXA - 10 mg - coated tablets - 35 tablets, per box.
Slovenian: EU/1/96/022/026 - ZYPREXA - 10 mg - obložene tablete - 35 tablet na škatlo.
English: EU/1/96/022/021 - ZYPREXA - 15 mg - coated tablets - 56 tablets, per box.
Slovenian: EU/1/96/022/021 - ZYPREXA - 15 mg - obložene tablete - 56 tablet na škatlo.
English: EU/1/96/022/036 - ZYPREXA - 5 mg - coated tablets - 98 tablets, per box.
Slovenian: EU/1/96/022/036 - ZYPREXA - 5 mg - obložene tablete - 98 tablet na škatlo.
English: EU/1/96/022/010 - ZYPREXA - 10 mg - coated tablets - 56 tablets, per box.
Slovenian: EU/1/96/022/010 - ZYPREXA - 10 mg - obložene tablete - 56 tablet na škatlo.
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 15 mg coated tablets Olanzapine
Slovenian: IME ZDRAVILA ZYPREXA 15 mg obložene tablete olanzapin
English: EU/1/96/022/020 - ZYPREXA - 5 mg - coated tablets - 56 tablets, per box.
Slovenian: EU/1/96/022/020 - ZYPREXA - 5 mg - obložene tablete - 56 tablet na škatlo.
English: EU/1/96/022/004 28 coated tablets EU/1/96/022/024 35 coated tablets EU/1/96/022/020 56 coated tablets EU/1/96/022/030 70 coated tablets EU/1/96/022/036 98 coated tablets
Slovenian: EU/1/96/022/004 28 obloženih tablet EU/1/96/022/024 35 obloženih tablet EU/1/96/022/020 56 obloženih tablet EU/1/96/022/030 70 obloženih tablet EU/1/96/022/036 98 obloženih tablet
English: EU/1/96/022/014 28 coated tablets EU/1/96/022/028 35 coated tablets EU/1/96/022/022 56 coated tablets EU/1/96/022/034 70 coated tablets EU/1/96/022/040 98 coated tablets
Slovenian: EU/1/96/022/014 28 obloženih tablet EU/1/96/022/028 35 obloženih tablet EU/1/96/022/022 56 obloženih tablet EU/1/96/022/034 70 obloženih tablet EU/1/96/022/040 98 obloženih tablet
English: Hydrochloric acid.
Slovenian: Rumeni liofilizirani prašek.
English: How to store ZYPREXA 6.
Slovenian: Kako uporabljati zdravilo ZYPREXA
English: EU/1/96/022/01128 coated tablets EU/1/96/022/025 35 coated tablets EU/1/96/022/006 56 coated tablets EU/1/96/022/031 70 coated tablets EU/1/96/022/037 98 coated tablets
Slovenian: EU/1/96/022/011 28 obloženih tablet EU/1/96/022/025 35 obloženih tablet EU/1/96/022/006 56 obloženih tablet EU/1/96/022/031 70 obloženih tablet EU/1/96/022/037 98 obloženih tablet
English: EU/1/96/022/012 28 coated tablets EU/1/96/022/027 35 coated tablets EU/1/96/022/021 56 coated tablets EU/1/96/022/033 70 coated tablets EU/1/96/022/039 98 coated tablets
Slovenian: EU/1/96/022/012 28 obloženih tablet EU/1/96/022/027 35 obloženih tablet EU/1/96/022/021 56 obloženih tablet EU/1/96/022/033 70 obloženih tablet EU/1/96/022/039 98 obloženih tablet
English: EU/1/96/022/009 28 coated tablets EU/1/96/022/026 35 coated tablets EU/1/96/022/010 56 coated tablets EU/1/96/022/032 70 coated tablets EU/1/96/022/038 98 coated tablets
Slovenian: EU/1/96/022/009 28 obloženih tablet EU/1/96/022/026 35 obloženih tablet EU/1/96/022/010 56 obloženih tablet EU/1/96/022/032 70 obloženih tablet EU/1/96/022/038 98 obloženih tablet
English: Eli Lilly Nederland B.V. Tel: + 31 (0)30 6025800
Slovenian: Tel: + 31 (0)30 6025800
English: Temporal association of olanzapine treatment and venous thromboembolism has been reported uncommonly (≥ 0.1 % and < 1 %).
Slovenian: Občasno ( ≥ 0.1% in < 1%) so poročali o občasnih povezavah med zdravljenjem z olanzapinom in vensko tromboembolijo.
English: EU/1/96/022/002 28 coated tablets EU/1/96/022/023 35 coated tablets EU/1/96/022/019 56 coated tablets EU/1/96/022/029 70 coated tablets EU/1/96/022/035 98 coated tablets
Slovenian: EU/1/96/022/002 28 obloženih tablet EU/1/96/022/023 35 obloženih tablet EU/1/96/022/019 56 obloženih tablet EU/1/96/022/029 70 obloženih tablet EU/1/96/022/035 98 obloženih tablet
English: ZYPREXA 5 mg coated tablets Round, white, coated tablets imprinted with “LILLY” and a numeric identicode “4115”.
Slovenian: Okrogle, bele, obložene tablete z vtisnjenim napisom "LILLY" in številčno identifikacijsko oznako “4115”.
English: Tablet core
Slovenian: tablet.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 10 mg COATED TABLETS: BLISTER FOIL LABEL
Slovenian: ZYPREXA 10 mg OBLOŽENE TABLETE: OZNAKA FOLIJE PRETISNEGA OMOTA
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS LABEL ON VIAL OF 10 mg POWDER
Slovenian: PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNIH OMOTIH ALI DVOJNIH TRAKOVIH
English: For further information on continued treatment with oral olanzapine (5 to 20 mg daily), see the Summary of Product Characteristics for ZYPREXA coated tablets or ZYPREXA VELOTAB orodispersible tablets.
Slovenian: Za nadaljnje informacije o vzdrževalnem zdravljenju s peroralnim olanzapinom (5 do 20 mg na dan)
English: ZYPREXA 2.5 mg coated tablets Round, white, coated tablets imprinted with “LILLY” and a numeric identicode “4112”.
Slovenian: Okrogle, bele, obložene tablete z vtisnjenim napisom "LILLY" in številčno identifikacijsko oznako “4112”.
English: Urinary hesitation11
Slovenian: Trombocitopenij a11